RECRUITING

PDA for Kidneys Study

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The goal of this observational study is to gather more information on kidney oxygen levels in babies with a patent ductus arteriosus (PDA), and evaluate the relationships between kidney oxygen levels, PDA status and kidney injury. Researchers will do this by looking at ultrasound images of the heart, analyzing substances in the urine, and evaluating oxygen levels in the kidneys.

Official Title

Development of a Novel Kidney-focused Approach to Treatment of a Patent Ductus Arteriosus (PDA) in Vulnerable Preterm Neonates - A Pilot Study

Quick Facts

Study Start:2024-12
Study Completion:2025-06
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06658496

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:1 Minute to 7 Days
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. * Delivered at \<32 weeks' gestation
  2. * ≤72 hours of age
  3. * Inpatient at Meriter Hospital, Inc. NICU
  4. * At least one parent/guardian is able to provide parental permission in English or Spanish
  1. * Major congenital anomalies of kidney
  2. * Attending physician's discretion to not place NIRS sensors due to clinical concerns
  3. * In the PI or Co-I's medical opinion, there is a significant likelihood that the neonate would not survive the first 3 days of life
  4. * Birth parent aged \<18

Contacts and Locations

Study Contact

Paige Condit, MD
CONTACT
616-481-9914
pcondit@wisc.edu
Meg Baker
CONTACT
meg.baker@wisc.edu

Principal Investigator

Matthew Harer, MD
PRINCIPAL_INVESTIGATOR
University of Wisconsin, Madison

Study Locations (Sites)

Meriter Hospital, Inc.
Madison, Wisconsin, 53715
United States

Collaborators and Investigators

Sponsor: University of Wisconsin, Madison

  • Matthew Harer, MD, PRINCIPAL_INVESTIGATOR, University of Wisconsin, Madison

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-12
Study Completion Date2025-06

Study Record Updates

Study Start Date2024-12
Study Completion Date2025-06

Terms related to this study

Keywords Provided by Researchers

  • neonate

Additional Relevant MeSH Terms

  • Patent Ductus Arteriosus
  • Congenital Heart Disease